Inland Chemidrugs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 38 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 131.27%
- Profit Growth 22.81%
- Ebitda -59.90%
- Net Worth -3.40%
- Total Assets 1.25%
About Inland Chemidrugs
Inland Chemidrugs Limited (ICL) is a Public Limited Indian Non-Government Company incorporated in India on 27 June 1986 and has a history of 38 years and seven months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Wadhwa, Amrita Wadhwa, and Suresh Wadhwa serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231PN1986PLC040244
-
Company No.
040244
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
27 Jun 1986
-
Date of AGM
26 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Inland Chemidrugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Wadhwa
|
Managing Director | 27-Jun-1986 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Rajesh Wadhwa
|
Director | 27-Jun-1986 | Current |
|
Amrita Wadhwa
|
Director | 31-Dec-1999 | Current |
Financial Performance of Inland Chemidrugs.
Inland Chemidrugs Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 131.27% increase. The company also saw a substantial improvement in profitability, with a 22.81% increase in profit. The company's net worth dipped by a decrease of 3.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inland Chemidrugs?
In 2020, Inland Chemidrugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Khar Garden Apartments LimitedRajesh Wadhwa is a mutual person
-
International Sindhu Chamber Of Commerce
Suresh Wadhwa is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Inland Chemidrugs?
Unlock and access historical data on people associated with Inland Chemidrugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inland Chemidrugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inland Chemidrugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.